HealthEquity, Inc. (NASDAQ:HQY) Projects Margin Strength To Support Near-Term Momentum

HealthEquity shows operating profitability gains alongside compressing topline growth, producing a setup where margin strength should underpin near-term price stability. Technical indicators point to low trend strength with mixed momentum signals that favor range-bound action with modest upward bias.

Recent News

On August 29, 2025 HealthEquity announced that its AI-powered benefits-education tool, HSAnswers, received multiple industry awards recognizing its generative-AI capabilities and benefits-education innovation. On August 6, 2025 the company set its second-quarter fiscal 2026 earnings release for September 2, 2025 and disclosed a schedule of investor conference presentations in early September.

Technical Analysis

ADX at 14.42 signals no established trend; this indicates price action likely remains range-bound until directional strength rises above the 20–25 band and validates a sustained move.

Directional indicators diverge: DI+ at 24.14 shows a peak-and-reversal pattern, indicating recent loss of bullish impetus; DI- at 18.42 decreasing signals reduction in selling pressure. Together these suggest short-term tug-of-war between buyers and sellers rather than a clear directional breakout.

MACD sits at 0.71 above its signal line at 0.37, which reflects a recent bullish cross, but the MACD trend registers a peak-and-reversal, implying momentum has started to wane despite the cross; monitor for whether the MACD completes the reversal or resumes an uptrend.

MRO reads -1.12 (increasing). A negative MRO indicates price currently below the WMDST target and implies potential upside pressure toward that target; the small magnitude suggests modest upward potential rather than an outsized gap to close.

RSI at 48.58 and increasing signals growing buying pressure from the midpoint, consistent with short-term support building just above the 20-day mean.

Price sits at $94.77, above the 20-day average ($94.13) and the 50-day average ($92.68) while remaining below the 200-day average ($96.92). The 12-day EMA rising at $94.52 supports near-term price support; the 200-day average places resistance slightly above current levels. Bollinger bands place the one‑standard‑deviation band roughly between $92.30 and $95.97, indicating current volatility remains contained inside recent trading bands.

Volume at 762,565 trades below 10-, 50- and 200-day averages, suggesting recent moves occurred on lighter participation and therefore lack broad conviction.

 


Fundamental Analysis

Profitability anchors the fundamental story. EBIT of $93,003,000 produces an EBIT margin of 28.54%, above the industry peer mean of 17.13% and above the industry peer median of 17.23%, reflecting material operating efficiency versus peers. EBIT margin rose QoQ by 10.05% and expanded YoY by 37.98%, reinforcing the improvement in operating leverage.

Operating margin at 27.89% and return on sales at 27.89% both sit well above the industry peer mean of 17.51%, reflecting a higher-than-peer conversion of revenue into operating profit. Return on equity of 2.79% exceeds the industry peer mean of 2.04%, while return on assets of 1.75% trails modestly above the peer mean of 1.10%, indicating capital returns align favorably with peers given the company’s capital intensity.

Top-line metrics show pressure. Total revenue equals $325,835,000 with revenue growth reported at -1.51% (quarter) and revenue growth year-over-year reported at -135.31% (YoY). QoQ revenue growth printed -124.812% (as provided). These figures show contraction on the topline measures provided and suggest revenue dynamics have slowed relative to the margin gains.

Market multiples sit above peer medians: P/E of 87.35 exceeds the industry peer mean of 70.39; price-to-book at 3.80 stands above the industry peer mean of 2.33; price-to-sales at 25.02 remains above the industry peer mean of 13.44. Free cash flow yield at 1.53% outpaces the industry peer mean of 0.57%, and free cash flow of $124,686,000 supports cash conversion metrics—operating cash flow of $135,866,000 and a cash conversion ratio of 0.866 reinforce cash generation versus accounting earnings.

Leverage and liquidity present a mixed picture. Total debt of $1,055,024,000 produces debt-to-assets of 30.88%, slightly above the industry peer mean of 30.15%, while the current ratio at 4.23 sits well above the industry peer mean of 2.03, indicating strong near-term liquidity. Interest coverage at 6.22 remains below the industry peer mean of 8.21 but stays positive and supportive of servicing obligations.

Reported EPS came in at $1.08 versus an estimate of $0.92, an EPS surprise ratio of 17.39%, and EPS difference of $0.16. Forward EPS sits at $0.9225 with a forward P/E of 106.86. WMDST values the stock as fair-valued, reflecting the balance between elevated multiples and stronger-than-peer margins and cash conversion.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2025-07-31
REPORT DATE: 2025-09-02
NEXT REPORT DATE: 2025-12-02
CASH FLOW  Begin Period Cash Flow 287.9 M
 Operating Cash Flow 135.9 M
 Capital Expenditures -11.18 M
 Change In Working Capital -11.16 M
 Dividends Paid
 Cash Flow Delta 16.6 M
 End Period Cash Flow 304.5 M
 
INCOME STATEMENT REVENUE
 Total Revenue 325.8 M
 Forward Revenue 108.5 M
COSTS
 Cost Of Revenue 93.2 M
 Depreciation 11.5 M
 Depreciation and Amortization 38.5 M
 Research and Development 64.8 M
 Total Operating Expenses 235.0 M
PROFITABILITY
 Gross Profit 232.6 M
 EBITDA 131.5 M
 EBIT 93.0 M
 Operating Income 90.9 M
 Interest Income 3.4 M
 Interest Expense 15.0 M
 Net Interest Income -11.59 M
 Income Before Tax 78.0 M
 Tax Provision 18.2 M
 Tax Rate 23.3 %
 Net Income 59.9 M
 Net Income From Continuing Operations 59.9 M
EARNINGS
 EPS Estimate 0.92
 EPS Actual 1.08
 EPS Difference 0.16
 EPS Surprise 17.391 %
 Forward EPS 0.92
 
BALANCE SHEET ASSETS
 Total Assets 3.4 B
 Intangible Assets 2.8 B
 Net Tangible Assets -654.18 M
 Total Current Assets 492.8 M
 Cash and Short-Term Investments 304.5 M
 Cash 304.5 M
 Net Receivables 111.2 M
 Inventory
 Long-Term Investments 80.4 M
LIABILITIES
 Accounts Payable 9.6 M
 Short-Term Debt
 Total Current Liabilities 116.6 M
 Net Debt 702.4 M
 Total Debt 1.1 B
 Total Liabilities 1.3 B
EQUITY
 Total Equity 2.1 B
 Retained Earnings 226.9 M
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 24.84
 Shares Outstanding 86.421 M
 Revenue Per-Share 3.77
VALUATION
 Market Capitalization 8.2 B
 Enterprise Value 8.9 B
 Enterprise Multiple 67.73
Enterprise Multiple QoQ -6.311 %
Enterprise Multiple YoY 11.276 %
Enterprise Multiple IPRWA high: 161.723
HQY: 67.73
median: 60.952
mean: 60.936
low: -62.011
 EV/R 27.325
CAPITAL STRUCTURE
 Asset To Equity 1.592
 Asset To Liability 2.69
 Debt To Capital 0.33
 Debt To Assets 0.309
Debt To Assets QoQ -4.686 %
Debt To Assets YoY 5384.725 %
Debt To Assets IPRWA high: 0.656
median: 0.314
HQY: 0.309
mean: 0.302
low: 0.188
 Debt To Equity 0.492
Debt To Equity QoQ -5.678 %
Debt To Equity YoY 5260.196 %
Debt To Equity IPRWA high: 4.753
median: 0.597
mean: 0.565
HQY: 0.492
low: 0.289
PRICE-BASED VALUATION
 Price To Book (P/B) 3.798
Price To Book QoQ -1.444 %
Price To Book YoY 21.602 %
Price To Book IPRWA HQY: 3.798
high: 2.529
median: 2.405
mean: 2.329
low: 0.984
 Price To Earnings (P/E) 87.353
Price To Earnings QoQ -10.236 %
Price To Earnings YoY -2.639 %
Price To Earnings IPRWA high: 351.269
HQY: 87.353
median: 70.629
mean: 70.394
low: -23.411
 PE/G Ratio 7.703
 Price To Sales (P/S) 25.022
Price To Sales QoQ 1.137 %
Price To Sales YoY 11.382 %
Price To Sales IPRWA HQY: 25.022
high: 13.712
mean: 13.442
median: 13.429
low: 0.679
FORWARD MULTIPLES
Forward P/E 106.858
Forward PE/G 9.423
Forward P/S 75.143
EFFICIENCY OPERATIONAL
 Operating Leverage -5.536
ASSET & SALES
 Asset Turnover Ratio 0.095
Asset Turnover Ratio QoQ -1.058 %
Asset Turnover Ratio YoY 7.495 %
Asset Turnover Ratio IPRWA high: 0.445
HQY: 0.095
median: 0.094
mean: 0.093
low: 0.0
 Receivables Turnover 2.865
Receivables Turnover Ratio QoQ 1.449 %
Receivables Turnover Ratio YoY 2.548 %
Receivables Turnover Ratio IPRWA high: 9.066
HQY: 2.865
mean: 1.346
low: 1.343
median: 1.343
 Inventory Turnover
Inventory Turnover Ratio QoQ
Inventory Turnover Ratio YoY
Inventory Turnover Ratio IPRWA
 Days Sales Outstanding (DSO) 31.844
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 21.953
Cash Conversion Cycle Days QoQ 0.0 %
Cash Conversion Cycle Days YoY
Cash Conversion Cycle Days IPRWA high: 261.049
mean: 169.673
median: 160.142
HQY: 21.953
low: -17.924
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 0.866
 CapEx To Revenue -0.034
 CapEx To Depreciation -0.976
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 3.2 B
 Net Invested Capital 3.2 B
 Invested Capital 3.2 B
 Net Tangible Assets -654.18 M
 Net Working Capital 376.3 M
LIQUIDITY
 Cash Ratio 2.612
 Current Ratio 4.228
Current Ratio QoQ 4.029 %
Current Ratio YoY 3.132 %
Current Ratio IPRWA HQY: 4.228
high: 3.656
mean: 2.026
median: 2.014
low: 0.577
 Quick Ratio
Quick Ratio QoQ
Quick Ratio YoY
Quick Ratio IPRWA
COVERAGE & LEVERAGE
 Debt To EBITDA 8.026
 Cost Of Debt 1.061 %
 Interest Coverage Ratio 6.219
Interest Coverage Ratio QoQ 7.678 %
Interest Coverage Ratio YoY 54.632 %
Interest Coverage Ratio IPRWA high: 8.398
median: 8.398
mean: 8.211
HQY: 6.219
low: -10.187
 Operating Cash Flow Ratio 0.854
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 9.891
DIVIDENDS
 Dividend Coverage Ratio
 Dividend Payout Ratio
 Dividend Rate
 Dividend Yield
PERFORMANCE GROWTH
 Asset Growth Rate 0.012 %
 Revenue Growth -1.514 %
Revenue Growth QoQ -124.812 %
Revenue Growth YoY -135.308 %
Revenue Growth IPRWA high: 13.274 %
HQY: -1.514 %
mean: -2.797 %
median: -3.909 %
low: -56.322 %
 Earnings Growth 11.34 %
Earnings Growth QoQ -72.055 %
Earnings Growth YoY 51.2 %
Earnings Growth IPRWA high: 53.659 %
median: 53.659 %
mean: 48.711 %
HQY: 11.34 %
low: -350.0 %
MARGINS
 Gross Margin 71.384 %
Gross Margin QoQ 5.286 %
Gross Margin YoY 4.924 %
Gross Margin IPRWA HQY: 71.384 %
high: 65.265 %
median: 65.015 %
mean: 64.988 %
low: 24.145 %
 EBIT Margin 28.543 %
EBIT Margin QoQ 10.047 %
EBIT Margin YoY 37.982 %
EBIT Margin IPRWA HQY: 28.543 %
high: 17.23 %
median: 17.23 %
mean: 17.128 %
low: -7.627 %
 Return On Sales (ROS) 27.891 %
Return On Sales QoQ 7.534 %
Return On Sales YoY 34.83 %
Return On Sales IPRWA HQY: 27.891 %
high: 17.673 %
median: 17.673 %
mean: 17.511 %
low: -3.623 %
CASH FLOW
 Free Cash Flow (FCF) 124.7 M
 Free Cash Flow Yield 1.529 %
Free Cash Flow Yield QoQ 157.407 %
Free Cash Flow Yield YoY -202.069 %
Free Cash Flow Yield IPRWA high: 5.888 %
HQY: 1.529 %
mean: 0.573 %
median: 0.507 %
low: -3.961 %
 Free Cash Growth 156.582 %
Free Cash Growth QoQ -816.229 %
Free Cash Growth YoY -409.212 %
Free Cash Growth IPRWA HQY: 156.582 %
high: 22.255 %
mean: -71.716 %
median: -71.774 %
low: -165.763 %
 Free Cash To Net Income 2.083
 Cash Flow Margin 30.538 %
 Cash Flow To Earnings 1.662
VALUE & RETURNS
 Economic Value Added 0.04
 Return On Assets (ROA) 1.752 %
Return On Assets QoQ 11.521 %
Return On Assets YoY 65.283 %
Return On Assets IPRWA HQY: 1.752 %
high: 1.139 %
median: 1.139 %
mean: 1.097 %
low: -2.046 %
 Return On Capital Employed (ROCE) 2.818 %
 Return On Equity (ROE) 0.028
Return On Equity QoQ 9.846 %
Return On Equity YoY 67.911 %
Return On Equity IPRWA HQY: 0.028
high: 0.022
median: 0.022
mean: 0.02
low: -0.654
 DuPont ROE 2.803 %
 Return On Invested Capital (ROIC) 2.262 %
Return On Invested Capital QoQ 10.288 %
Return On Invested Capital YoY -114.578 %
Return On Invested Capital IPRWA HQY: 2.262 %
high: 1.555 %
median: 1.555 %
mean: 1.486 %
low: -11.418 %

Six-Week Outlook

Expect range-bound action with a modest upward bias while margin strength supports price stability. Low ADX indicates trend formation remains incomplete; MACD’s peak-and-reversal warns momentum could ebb unless the indicator re-accelerates above its signal line on expanding volume. MRO’s small negative reading suggests limited constructive pressure toward the WMDST target, and a rising RSI supports incremental buyer participation. Liquidity metrics and cash flow provide a fundamental backstop to price, while the 200-day average near $96.92 represents the nearest structural resistance level.

About HealthEquity, Inc.

HealthEquity, Inc. (NASDAQ:HQY) delivers technology-driven services that empower individuals to make informed healthcare financial decisions. Based in Draper, Utah, HealthEquity provides a comprehensive suite of cloud-based platforms designed to optimize health savings and spending. The company offers health savings accounts (HSAs), flexible spending accounts (FSAs), and health reimbursement arrangements (HRAs), equipping users with the tools to efficiently manage healthcare expenses. HealthEquity’s platforms enable users to pay medical bills, access personalized benefits information, and earn wellness incentives. The company also provides a robust investment platform, including an online-only automated investment advisory service, allowing individuals to grow their savings and make informed investment choices. Additionally, HealthEquity administers pre-tax commuter benefit programs and services under the Consolidated Omnibus Budget Reconciliation Act (COBRA). The company collaborates with a diverse network of health plans, benefits administrators, brokers, consultants, and retirement plan record-keepers. Through its direct sales force and strategic partnerships, HealthEquity enhances the healthcare experience for consumers and employers across the United States, promoting financial wellness and informed decision-making in healthcare.



© 2025 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.